Bespoke ExtractsBSPK 16 EBIT per Share is $-0.06 as of Sep. 2025. GuruFocus rates BSPK with a GF Score™ of 16/100 and a GF Value™ of $0.21 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 811 Drug Manufacturers companies, Bespoke Extracts ranks better than 65.35% on this metric.
Bespoke Extracts's EBIT per Share for the
three
months ended in Sep. 2025 was $-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.06.
During the past 3 years, the average EBIT per Share Growth Rate was 17.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Bespoke Extracts's EBIT per Share or its related term are showing as below:
BSPK'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -24.3 Med: 18.45 Max: 73.6
Current: 17.5
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Bespoke Extracts was 73.60% per year. The lowest was -24.30% per year. And the median was 18.45% per year.
BSPK's 3-Year EBIT Growth Rate is ranked better than 65.35% of 811
companies
in the Drug Manufacturers industry
Industry Median: 7.8
vs BSPK: 17.50
Bespoke Extracts (OTCPK:BSPK) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Bespoke Extracts EBIT per Share Related Terms
Bespoke Extracts EBIT per Share Historical Data
* Premium members only.
The historical data trend for Bespoke Extracts's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bespoke Extracts (BSPK) has a EBIT per Share of $-0.06 as of Sep. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bespoke Extracts and its competitors. According to the industry distribution chart, Bespoke Extracts ranks #281 out of 811 companies in the Drug Manufacturers industry, placing it in the top 34.6%.
Is Bespoke Extracts' EBIT per Share too high?
Bespoke Extracts' current EBIT per Share is $-0.06. Based on the distribution chart, Bespoke Extracts ranks #281 out of 811 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Bespoke Extracts has a GF Score™ of 16/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bespoke Extracts' EBIT per Share compare to IMCC and NPHC?
According to the Drug Manufacturers industry distribution chart, Bespoke Extracts ranks #281 out of 811 companies for EBIT per Share. This puts Bespoke Extracts in the upper half of its industry. The industry median EBIT per Share is 7.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.80, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Bespoke Extracts and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bespoke Extracts's current EBIT per Share is $-0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bespoke Extracts stock overvalued right now?
Based on GuruFocus' analysis, Bespoke Extracts (BSPK) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.12 — trading 42.7% below its estimated fair value. The current EBIT per Share is $-0.06. Bespoke Extracts' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Bespoke Extracts (BSPK), the current EBIT per Share is $-0.06 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bespoke Extracts (BSPK) Overvalued in 2026?
Based on GuruFocus' analysis, Bespoke Extracts stock appears to be undervalued.
The current stock price of $0.12 is trading 42.7% below its estimated GF Value™ of $0.21.
GuruFocus considers Bespoke Extracts to be Possible Value Trap.
Key valuation signals for BSPK:
EBIT per Share: $-0.06
GF Value™: $0.21 vs. price of $0.12 (42.7% below fair value)
No single metric tells the full story. See the BSPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, quality, hemp-derived CBD products. The company owns, manufactures, and distributes a portfolio of cannabis consumer packaged goods brands including Fresh Joints, Doobskis, DutchBlunts, and Wee Joints, to licensed marijuana dispensaries across Colorado.
16GF Score
Get the complete analysis for BSPK
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSPK has been successfully added to your 
